Published in J Radiat Res on June 14, 2012
Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling. Biomed Res Int (2015) 0.84
Endothelial perturbations and therapeutic strategies in normal tissue radiation damage. Radiat Oncol (2014) 0.80
Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression. Antioxid Redox Signal (2016) 0.79
Nuclear Countermeasure Activity of TP508 Linked to Restoration of Endothelial Function and Acceleration of DNA Repair. Radiat Res (2016) 0.75
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71
How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol (2001) 14.05
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res (2003) 13.22
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (1982) 11.24
Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science (2003) 7.86
Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res (2002) 4.83
AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem (2003) 3.02
Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer (2005) 2.65
Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res (2001) 2.38
AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ Res (2005) 2.06
AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res (2005) 2.02
Radiation oncology: a century of achievements. Nat Rev Cancer (2004) 1.98
Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res (2009) 1.95
Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys (2010) 1.89
The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol (2005) 1.83
Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res (2012) 1.70
Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res (2005) 1.60
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ (2009) 1.52
p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J (2002) 1.46
The response of the microvascular system to radiation: a review. Cancer Invest (1989) 1.39
Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res (2009) 1.36
Endogenous inhibitors of angiogenesis: a historical review. Leuk Res (2008) 1.34
Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer (2005) 1.25
Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells. Mol Cancer Res (2003) 1.17
Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin. J Biol Chem (2010) 1.16
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res (1998) 1.13
Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation. J Biol Chem (2011) 1.07
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J (1998) 1.05
p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr. Oncogene (2002) 1.03
Radiation-induced interleukin-6 expression through MAPK/p38/NF-kappaB signaling pathway and the resultant antiapoptotic effect on endothelial cells through Mcl-1 expression with sIL6-Ralpha. Int J Radiat Oncol Biol Phys (2009) 0.98
An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface. J Biol Chem (2004) 0.95
AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Biochem Pharmacol (2010) 0.95
Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis. Lab Invest (2005) 0.94
Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int J Oncol (2002) 0.92
Ionizing radiation enhances IL-6 and IL-8 production by human endothelial cells. Mediators Inflamm (1997) 0.86
Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats. J Radiat Res (2010) 0.85
Radiosensitivity and sublethal damage repair in human umbilical cord vein endothelial cells. Int J Radiat Oncol Biol Phys (1987) 0.85
HUVEC respond to radiation by inducing the expression of pro-angiogenic microRNAs. Radiat Res (2011) 0.85
The clonogenic response of bovine aortic endothelial cells in culture to radiation. Radiat Res (1986) 0.81
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep (2012) 1.66
Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer (2003) 1.01
Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. Int J Radiat Oncol Biol Phys (2005) 1.01
Synergistic effects of radiation and beta-lapachone in DU-145 human prostate cancer cells in vitro. Radiat Res (2006) 1.01
Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk. J Korean Med Sci (2006) 0.98
Endoplasmic reticulum stress-induced JNK activation is a critical event leading to mitochondria-mediated cell death caused by β-lapachone treatment. PLoS One (2011) 0.98
Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials (2012) 0.97
Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer. Int J Radiat Oncol Biol Phys (2012) 0.96
Nanoscale thickness and roughness control of gravure printed MEH-PPV layer by solvent printing for organic light emitting diode. J Nanosci Nanotechnol (2010) 0.96
Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv Mater (2010) 0.95
Oxidative stress in pregnant women and birth weight reduction. Reprod Toxicol (2005) 0.95
Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells. Neoplasia (2007) 0.94
Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells. Int J Hyperthermia (2011) 0.89
Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells. Invest New Drugs (2010) 0.89
β-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells. PLoS One (2011) 0.89
The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy. Int J Radiat Oncol Biol Phys (2005) 0.89
Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization. J Control Release (2009) 0.87
Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer. Lung Cancer (2010) 0.85
Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1. Anticancer Drugs (2009) 0.85
Heat shock increases expression of NAD(P)H:quinone oxidoreductase (NQO1), mediator of beta-lapachone cytotoxicity, by increasing NQO1 gene activity and via Hsp70-mediated stabilisation of NQO1 protein. Int J Hyperthermia (2009) 0.84
Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol (2006) 0.84
Bi-layer gravure printed nanoscale thick organic layers for organic light emitting diode. J Nanosci Nanotechnol (2011) 0.82
Cl- -channel is essential for LDL-induced cell proliferation via the activation of Erk1/2 and PI3k/Akt and the upregulation of Egr-1 in human aortic smooth muscle cells. Mol Cells (2008) 0.82
Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy. Int J Nanomedicine (2012) 0.82
HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis. Sci Rep (2013) 0.81
Cytotoxicity of perillyl alcohol against cancer cells is potentiated by hyperthermia. Int J Radiat Oncol Biol Phys (2003) 0.81
Anti-cancer effect of bio-reductive drug beta-lapachon is enhanced by activating NQO1 with heat shock. Int J Hyperthermia (2008) 0.80
The radiosensitivity of endothelial cells isolated from human breast cancer and normal tissue in vitro. Microvasc Res (2012) 0.80
Genome-wide identification of haploinsufficiency in fission yeast. J Microbiol Biotechnol (2008) 0.80
The anti-tumour compound, RH1, causes mitochondria-mediated apoptosis by activating c-Jun N-terminal kinase. Br J Pharmacol (2011) 0.79
Synergistic effect of ionizing radiation and beta-Lapachone against RKO human colon adenocarcinoma cells. Cancer Res Treat (2005) 0.78
n-Type reduced graphene oxide field-effect transistors (FETs) from photoactive metal oxides. Chemistry (2012) 0.78
c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiotherapeutic efficacy in non-small cell lung cancer. Int J Oncol (2011) 0.78
NQO1 prevents radiation-induced aneuploidy by interacting with Aurora-A. Carcinogenesis (2013) 0.78
Genome-wide drug-induced haploinsufficient screening of fission yeast for identification of hydrazinocurcumin targets. J Microbiol Biotechnol (2008) 0.77
Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells. Int J Hyperthermia (2010) 0.77
Enhancement of radiotherapeutic effectiveness by temperature-sensitive liposomal 1-methylxanthine. Int J Pharm (2009) 0.77
Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB. Exp Mol Med (2010) 0.76
Potential predictive markers for proliferative capacity of cultured human articular chondrocytes: PCNA and p21. Artif Organs (2005) 0.76
Effect of pH on radiation-induced p53 expression. Int J Radiat Oncol Biol Phys (2004) 0.76
Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2005) 0.76
Aurora-a contributes to radioresistance by increasing NF-kappaB DNA binding. Radiat Res (2010) 0.76
Mesoporous Silica Nanocarriers with Cyclic Peptide Gatekeeper: Specific Targeting of Aminopeptidase N and Triggered Drug Release by Stimuli-Responsive Conformational Transformation. Chemistry (2017) 0.75
Radiosensitization of tumor cells by modulation of ATM kinase. Int J Radiat Biol (2006) 0.75
1-Methylxanthine enhances the radiosensitivity of tumor cells. Int J Radiat Biol (2009) 0.75